MINOXIDIL (FOR WOMEN)

Post-LOE

minoxidil topical solution 2%

Taro

ANDATOPICALSOLUTION

Approved

Nov 2024

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

1/8 — Limited

Drug data last refreshed 2h ago

Mechanism of Action

Pharmacologic Class:

Arteriolar Vasodilator

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

Company

Taro

See all Taro products →

Worked on MINOXIDIL (FOR WOMEN) at Taro? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.